论文期刊

取消

高级检索

检索历史清除

首页> Blood cancer journal> All-trans retinoic acid 45 mg/m<sup>2</sup> is superior to 25 mg/m<sup>2</sup> as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting.

All-trans retinoic acid 45 mg/m<sup>2</sup> is superior to 25 mg/m<sup>2</sup> as the first induction regimen for the treatment of acute promyelocytic leukaemia: a retrospective analysis in a real-world clinical setting.

导出 OA

翻译打印收藏纠错

作者： Xinhui,Zhang ^[1] ; Shanglong,Feng ^[1] ; Jin,Xu ^[2] ; Na,Zhao ^[3] ; Xing,Hu ^[2] ; Li,Zhou ^[2] ; Juan,Tong ^[2] ; Lei,Xue ^[2] ; Lei,Zhang ^[2] ; Yongsheng,Han ^[2] ; Xingbing,Wang ^[2] ; Liangquan,Geng ^[2] ; Xiaoyu,Zhu ^[2] ; Baolin,Tang ^[2] ; Huilan,Liu ^[2] ; Weibo,Zhu ^[2] ; Xiaoyan,Cai ^[2] ; Xin,Liu ^[2] ; Zimin,Sun ^[2] ; Changcheng,Zheng ^[2]

作者单位： Department of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, China. ^[1] Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. ^[2] Wannan Medical College, Wuhu, China. ^[3] Department of Hematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, China. zhengchch1123@ustc.edu.cn. ^[4] Department of Hematology, the First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China. zhengchch1123@ustc.edu.cn. ^[5]

主题词青少年(Adolescent);成年人(Adult);老年人(Aged);抗肿瘤药(Antineoplastic Agents);儿童(Child);剂量效应关系, 药物(Dose-Response Relationship, Drug);女(雌)性(Female);人类(Humans);白血病, 早幼粒细胞, 急性(Leukemia, Promyelocytic, Acute);男(雄)性(Male);中年人(Middle Aged);回顾性研究(Retrospective Studies);维甲酸(Tretinoin);青年人(Young Adult)

DOI 10.1038/s41408-021-00411-9

PMID 33514684

发布时间 2021-08-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Blood cancer journal

Blood cancer journal

2021年11卷1期

15页

相似文献

中文期刊
外文期刊
学位论文
会议论文

特别提示：本网站仅提供医学学术资源服务，不销售任何药品和器械，有关药品和器械的销售信息，请查阅其他网站。

客服热线：4000-115-888 转3 (周一至周五：8:00至17:00)
|
客服邮箱：yiyao@wanfangdata.com.cn

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

官方微信

万方医学小程序

关于我们网站地图知识产权

北京万方数据股份有限公司

万方数据电子出版社

京ICP证010071号

京公网安备11010802020237号

京ICP备08100800号-1

违法和不良信息举报电话：4000-115-888，举报邮箱：problem@wanfangdata.com.cn，举报专区

new翻译充值订阅收藏移动端

官方微信

万方医学小程序

调查问卷